| Product Code: ETC417566 | Publication Date: Oct 2022 | Updated Date: Jul 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The Vietnam Gastrointestinal Diseases Market was estimated at USD 237 Million in 2025 and is projected to reach USD 334 Million by 2032, growing at a CAGR of 5.0% from 2026 to 2032. This growth trajectory is driven by the increasing prevalence of gastrointestinal disorders alongside shifting dietary patterns among the Vietnamese population. Additionally, advancements in medical technologies and heightened awareness regarding gastrointestinal health are encouraging individuals to seek timely diagnosis and treatment.
This graph highlights how the Vietnam Gastrointestinal Diseases Market has steadily grown over the years, supported by major growth factors.

The table below presents the year‑wise growth rates along with the key drivers influencing the market
| Year | Growth Rate | Major Drivers |
| 2021 | 3.4% | Rising healthcare investment initiatives |
| 2022 | 2.9% | Increasing awareness of nutrition |
| 2023 | 8.2% | Growth in advanced medical technologies |
| 2024 | 5.2% | Expansion of healthcare infrastructure |
| 2025 | 6.3% | Surge in preventive health measures |
| 2026 | 7.9% | Increase in population health screenings |
| 2027 | 7.5% | growing downstream application demand |
| 2028 | 6.6% | Rising demand for personalized medicine |
| 2029 | 5.8% | improved raw material availability |
| 2030 | 5.7% | growing regional consumption patterns |
| 2031 | 5.8% | increased overall sector activity |
| 2032 | 5.6% | Rising collaboration among healthcare providers |
Note: Market size estimations and growth projections presented in this report are based on 6Wresearch's proprietary forecasting methodology, utilizing the latest available industry data, government publications, and primary research inputs.
In recent years, the Vietnam Gastrointestinal Diseases market has witnessed significant growth, fueled by rising incidences of conditions such as gastritis and irritable bowel syndrome. The outlook remains positive as healthcare infrastructure improves and awareness initiatives enhance early diagnosis and treatment options for patients.
As the market evolves, it is becoming increasingly evident that the demand for innovative therapies and advanced diagnostic tools is on the rise. The growth of gastroenterology clinics and an increase in public health campaigns are further propelling this sector towards a promising future.
Despite its growth potential, the Vietnam Gastrointestinal Diseases market faces significant challenges, particularly related to healthcare accessibility. Rural areas often experience disparities in service availability, leading to delayed diagnosis and treatment. Additionally, many patients struggle with the affordability of effective treatments, which limits access to the latest therapies. This situation emphasizes the need for enhanced healthcare infrastructure and targeted public health measures to address the high prevalence of gastrointestinal diseases.
The market is currently witnessing several trends that are shaping its future. An increasing focus on preventive healthcare is driving demand for early screening and diagnostic tools. Additionally, there is a shift towards minimally invasive procedures, which provide patients with safer and more effective treatment options. The integration of telemedicine is also gaining traction, allowing patients to access healthcare services remotely, especially during and after the COVID-19 pandemic. These trends are not only enhancing patient experiences but also driving innovation within the industry.
The Vietnam Gastrointestinal Diseases market holds substantial growth opportunities, particularly in the development of novel therapies and advanced diagnostic tools. Investment in healthcare infrastructure is also essential, especially in underserved rural regions. Furthermore, public-private partnerships could facilitate improved access to treatments, potentially leading to significant market expansion. The increasing emphasis on preventive care and wellness also presents new avenues for companies looking to invest in this sector.
The Vietnamese government has recognized the rising burden of gastrointestinal diseases and is actively investing in healthcare improvements. Public health campaigns are being implemented to raise awareness about dietary habits and gastrointestinal health. Additionally, policies aimed at enhancing healthcare access in rural areas are being prioritized. Such initiatives aim to improve overall public health outcomes and facilitate timely intervention for gastrointestinal disorders across the country.
Looking ahead to the period between 2026 and 2032, the Vietnam Gastrointestinal Diseases market is set to experience robust growth driven by demographic shifts, such as an aging population increasingly susceptible to these conditions. As healthcare technology continues to evolve, the introduction of innovative treatment options will likely enhance patient care and expand market offerings. Moreover, government initiatives aimed at promoting health literacy will further bolster market expansion, paving the way for a healthier population.
Recent industry developments have focused on expanding access to gastrointestinal care through the establishment of new clinics and enhanced telehealth services. Innovations in treatment protocols and the introduction of new diagnostic technologies have gained traction, enabling more effective management of gastrointestinal disorders. As the healthcare landscape continues to shift post-pandemic, collaborations between public health authorities and private sector stakeholders are expected to strengthen service delivery in this market.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Vietnam Gastrointestinal Diseases Market Overview |
3.1 Vietnam Country Macro Economic Indicators |
3.2 Vietnam Gastrointestinal Diseases Market Revenues & Volume, 2022 & 2032F |
3.3 Vietnam Gastrointestinal Diseases Market - Industry Life Cycle |
3.4 Vietnam Gastrointestinal Diseases Market - Porter's Five Forces |
3.5 Vietnam Gastrointestinal Diseases Market Revenues & Volume Share, By Drug Type, 2022 & 2032F |
3.6 Vietnam Gastrointestinal Diseases Market Revenues & Volume Share, By Dosage Form, 2022 & 2032F |
3.7 Vietnam Gastrointestinal Diseases Market Revenues & Volume Share, By Application, 2022 & 2032F |
4 Vietnam Gastrointestinal Diseases Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of gastrointestinal diseases in Vietnam. |
4.2.2 Growing awareness about gastrointestinal health and the importance of early diagnosis and treatment. |
4.2.3 Advancements in medical technology and treatment options for gastrointestinal diseases. |
4.3 Market Restraints |
4.3.1 Limited access to healthcare facilities in rural areas of Vietnam. |
4.3.2 High cost of gastrointestinal disease treatment and medications. |
4.3.3 Lack of skilled healthcare professionals specializing in gastrointestinal diseases in Vietnam. |
5 Vietnam Gastrointestinal Diseases Market Trends |
6 Vietnam Gastrointestinal Diseases Market, By Types |
6.1 Vietnam Gastrointestinal Diseases Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Vietnam Gastrointestinal Diseases Market Revenues & Volume, By Drug Type, 2022-2032F |
6.1.3 Vietnam Gastrointestinal Diseases Market Revenues & Volume, By Antacids, 2022-2032F |
6.1.4 Vietnam Gastrointestinal Diseases Market Revenues & Volume, By Laxatives, 2022-2032F |
6.1.5 Vietnam Gastrointestinal Diseases Market Revenues & Volume, By Antidiarrheal Agents, 2022-2032F |
6.1.6 Vietnam Gastrointestinal Diseases Market Revenues & Volume, By Antiemetics, 2022-2032F |
6.1.7 Vietnam Gastrointestinal Diseases Market Revenues & Volume, By Antiulcer Agents, 2022-2032F |
6.1.8 Vietnam Gastrointestinal Diseases Market Revenues & Volume, By Other, 2022-2032F |
6.2 Vietnam Gastrointestinal Diseases Market, By Dosage Form |
6.2.1 Overview and Analysis |
6.2.2 Vietnam Gastrointestinal Diseases Market Revenues & Volume, By Oral, 2022-2032F |
6.2.3 Vietnam Gastrointestinal Diseases Market Revenues & Volume, By Parenteral, 2022-2032F |
6.2.4 Vietnam Gastrointestinal Diseases Market Revenues & Volume, By Other, 2022-2032F |
6.3 Vietnam Gastrointestinal Diseases Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Vietnam Gastrointestinal Diseases Market Revenues & Volume, By Ulcerative Colitis, 2022-2032F |
6.3.3 Vietnam Gastrointestinal Diseases Market Revenues & Volume, By Irritable Bowel Syndrome, 2022-2032F |
6.3.4 Vietnam Gastrointestinal Diseases Market Revenues & Volume, By Crohn Disease, 2022-2032F |
6.3.5 Vietnam Gastrointestinal Diseases Market Revenues & Volume, By Celiac Disease, 2022-2032F |
6.3.6 Vietnam Gastrointestinal Diseases Market Revenues & Volume, By Gastroenteritis, 2022-2032F |
6.3.7 Vietnam Gastrointestinal Diseases Market Revenues & Volume, By Other, 2022-2032F |
7 Vietnam Gastrointestinal Diseases Market Import-Export Trade Statistics |
7.1 Vietnam Gastrointestinal Diseases Market Export to Major Countries |
7.2 Vietnam Gastrointestinal Diseases Market Imports from Major Countries |
8 Vietnam Gastrointestinal Diseases Market Key Performance Indicators |
8.1 Average waiting time for gastrointestinal disease diagnosis and treatment. |
8.2 Percentage of population undergoing regular screenings for gastrointestinal diseases. |
8.3 Number of public health campaigns or initiatives focused on gastrointestinal health awareness in Vietnam. |
9 Vietnam Gastrointestinal Diseases Market - Opportunity Assessment |
9.1 Vietnam Gastrointestinal Diseases Market Opportunity Assessment, By Drug Type, 2022 & 2032F |
9.2 Vietnam Gastrointestinal Diseases Market Opportunity Assessment, By Dosage Form, 2022 & 2032F |
9.3 Vietnam Gastrointestinal Diseases Market Opportunity Assessment, By Application, 2022 & 2032F |
10 Vietnam Gastrointestinal Diseases Market - Competitive Landscape |
10.1 Vietnam Gastrointestinal Diseases Market Revenue Share, By Companies, 2025 |
10.2 Vietnam Gastrointestinal Diseases Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here